Study Design: A Window of Opportunity Clinical Trial. This study design permits examination
of effects of an oral agent on cancer patients during the "window" between diagnosis of their
cancer and their definitive cancer surgery. Similar to a phase 0 study, the trial design
permits examination of the biologic effects of an agent; in this study pharmacokinetic
properties will be examined.